Benzinga's Top Initiations
- Credit Suisse initiated coverage of Allergan plc (NYSE: AGN) with a Outperform rating. The price target for Allergan is set to $327. Allergan shares rose 1.09 percent to $251.70 in pre-market trading.
- Analysts at Piper Jaffray initiated coverage of Syros Pharmaceuticals Inc (NASDAQ: SYRS) with a Overweight rating. Syros Pharmaceuticals shares rose 4.80 percent to $12.00 in pre-market trading.
- Pacific Crest initiated coverage on Level 3 Communications, Inc. (NYSE: LVLT) with a Sector Weight rating. Level 3 Communications shares rose 0.94 percent to close at $56.90 on Thursday.
- Analysts at Morgan Stanley assumed VMware, Inc. (NYSE: VMW) with a Overweight rating. The price target for VMware is set to $86. VMware shares gained 0.70 percent to $72.05 in pre-market trading.
- Analysts at Oppenheimer initiated coverage on Global Medical REIT Inc (NYSE: GMRE) with a Outperform rating. The price target for Global Medical REIT is set to $12. Global Medical REIT shares rose 2 percent to close at $10.73 on Thursday.
- Analysts at Bank of America initiated coverage on Casey's General Stores Inc (NASDAQ: CASY) with a Buy rating. Casey's shares gained 0.59 percent to $134.30 in pre-market trading.
- Analysts at FBR Capital initiated coverage on Aemetis Inc (NASDAQ: AMTX) with a Market Perform rating. Aemetis shares dropped 0.50 percent to close at $1.99 on Thursday.
- Analysts at Cowen & Co. initiated coverage on Syros Pharmaceuticals Inc (NASDAQ: SYRS) with a Outperform rating. Syros Pharmaceuticals shares gained 4.80 percent to $12.00 in pre-market trading.
Latest Ratings for SYRS
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 2021 | Roth Capital | Maintains | Buy | |
| Nov 2020 | HC Wainwright & Co. | Upgrades | Neutral | Buy |
| Mar 2020 | HC Wainwright & Co. | Reiterates | Neutral |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Top InitiationsInitiation Analyst Ratings
